EA200501285A1 - Способ получения липосомальных препаратов - Google Patents
Способ получения липосомальных препаратовInfo
- Publication number
- EA200501285A1 EA200501285A1 EA200501285A EA200501285A EA200501285A1 EA 200501285 A1 EA200501285 A1 EA 200501285A1 EA 200501285 A EA200501285 A EA 200501285A EA 200501285 A EA200501285 A EA 200501285A EA 200501285 A1 EA200501285 A1 EA 200501285A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- liposomal
- methods
- organic solvent
- main
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Данное изобретение представляет способы получения липосомальных препаратов. Согласно способам липидную фракцию растворяют в смешивающемся с водой органическом растворителе. Данный раствор, содержащий липидную фракцию, может быть добавлен и смешан с водным раствором в условиях формирования основного липосомального препарата. Желательно, когда препарат может включать один или более активных элементов. Основной липосомальный препарат может быть далее обработан, как требуется, например, путем фракционирования или уменьшения размера, удаления смешивающегося с водой органического растворителя, сублимационной сушки или другой обработки. Способы обеспечивают получение липосомальных препаратов на высоком или коммерческом уровне.Отчет о международном поиске был опубликован 2004.12.02.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44689503P | 2003-02-11 | 2003-02-11 | |
PCT/US2004/004555 WO2004071466A2 (en) | 2003-02-11 | 2004-02-11 | Manufacturing process for liposomal preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200501285A1 true EA200501285A1 (ru) | 2006-02-24 |
Family
ID=32869567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200501285A EA200501285A1 (ru) | 2003-02-11 | 2004-02-11 | Способ получения липосомальных препаратов |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060034908A1 (ru) |
EP (1) | EP1613284A2 (ru) |
JP (1) | JP2006517594A (ru) |
KR (1) | KR20050105455A (ru) |
CN (1) | CN1753657A (ru) |
BR (1) | BRPI0407415A (ru) |
EA (1) | EA200501285A1 (ru) |
MX (1) | MXPA05008489A (ru) |
WO (1) | WO2004071466A2 (ru) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005302255A1 (en) * | 2004-10-28 | 2006-05-11 | Alza Corporation | Lyophilized liposome formulations and method |
WO2006050072A2 (en) * | 2004-10-29 | 2006-05-11 | Neopharm, Inc. | Manufacturing process for liposomal preparations |
US20080121733A1 (en) * | 2006-11-29 | 2008-05-29 | Donald Ackley | Droplet generating device and method |
US7824708B2 (en) * | 2006-12-11 | 2010-11-02 | Access Business Group International Llc | Liposome containing cardiolipin for improvement of mitochondrial function |
AU2008227852B2 (en) * | 2007-03-19 | 2011-02-24 | Fresenius Kabi Oncology Ltd. | Proliposomal and liposomal compositions |
KR20080101056A (ko) * | 2007-05-15 | 2008-11-21 | 한국화학연구원 | 지질나노입자를 포함하는 디테르페노이드 알칼로이드계약물 용액 및 이의 제조방법 |
WO2009039628A1 (en) | 2007-09-27 | 2009-04-02 | Immunovaccine Technologies Inc. | Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
US20100209452A1 (en) * | 2007-10-03 | 2010-08-19 | Immunovaccine Technologies, Inc | Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
CA2723918C (en) | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
US9445975B2 (en) * | 2008-10-03 | 2016-09-20 | Access Business Group International, Llc | Composition and method for preparing stable unilamellar liposomal suspension |
KR20110110086A (ko) * | 2008-12-24 | 2011-10-06 | 가부시키가이샤 바이오메드코어 | 리포솜의 제조방법 및 콜레스테롤의 용해방법 |
WO2010118200A2 (en) * | 2009-04-08 | 2010-10-14 | Brian Salvatore | Liposomal formulations of tocopheryl amides |
JP5771366B2 (ja) | 2009-09-02 | 2015-08-26 | 株式会社バイオメッドコア | リポソーム製造装置及び方法 |
EP2480208A1 (en) | 2009-09-23 | 2012-08-01 | Indu Javeri | Methods for the preparation of liposomes |
US10143652B2 (en) | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
CN103002878B (zh) | 2010-04-09 | 2015-07-01 | 帕西拉制药有限公司 | 用于配制大直径合成膜囊泡的方法 |
DK2729127T3 (en) * | 2011-07-04 | 2018-08-06 | Statens Seruminstitut | METHODS FOR LIPOSOMES PREPARATION |
CN103181898B (zh) * | 2012-11-23 | 2016-03-09 | 杭州师范大学 | 一种奥沙利铂脂质体及其应用 |
JP2015193580A (ja) * | 2014-03-31 | 2015-11-05 | テルモ株式会社 | アムホテリシンbリポソームの製造方法 |
EP3302435B1 (en) * | 2015-05-26 | 2023-03-08 | Plumb Pharmaceuticals, Inc. | Liposome loading |
US20180280300A1 (en) * | 2015-10-07 | 2018-10-04 | Ensuiko Sugar Refining Co., Ltd. | Liposome including taxane compound |
EP3388055B1 (en) * | 2015-12-08 | 2021-11-17 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Method for preparing liposome |
WO2017097197A1 (zh) * | 2015-12-08 | 2017-06-15 | 正大天晴药业集团股份有限公司 | 美西替康的药物组合物 |
WO2019045097A1 (ja) | 2017-09-04 | 2019-03-07 | 一丸ファルコス株式会社 | pH感受性リポソームおよびその製造方法 |
WO2019191627A1 (en) * | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
CN109925956A (zh) * | 2019-04-29 | 2019-06-25 | 苏州艾特森制药设备有限公司 | 一种实验室脂质体制备*** |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665710A (en) * | 1990-04-30 | 1997-09-09 | Georgetown University | Method of making liposomal oligodeoxynucleotide compositions |
ATE194767T1 (de) * | 1992-03-23 | 2000-08-15 | Univ Georgetown | In liposomen verkapseltes taxol und verwendungsverfahren |
EP0706374B1 (en) * | 1993-06-30 | 1997-12-10 | Genentech, Inc. | Method for preparing liposomes |
KR970701551A (ko) * | 1994-03-11 | 1997-04-12 | 고야 마사시 | 리포좀 제제(liposome preparation) |
US6066331A (en) * | 1994-07-08 | 2000-05-23 | Barenholz; Yechezkel | Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers |
US6156337A (en) * | 1994-07-08 | 2000-12-05 | Opperbas Holding B.V. | Method for high loading of vesicles with biopolymeric substances |
DE69509103T2 (de) * | 1994-08-25 | 1999-09-30 | Pepscan Systems Bv | Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv-infektionen |
US6120795A (en) * | 1996-03-27 | 2000-09-19 | Ortho Pharmaceutical Corp. | Manufacture of liposomes and lipid-protein complexes by ethanolic injection and thin film evaporation |
US6559129B1 (en) * | 1997-03-21 | 2003-05-06 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
US7262173B2 (en) * | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
US6126965A (en) * | 1997-03-21 | 2000-10-03 | Georgetown University School Of Medicine | Liposomes containing oligonucleotides |
US20030229040A1 (en) * | 1997-03-21 | 2003-12-11 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
JP4656675B2 (ja) * | 1997-05-14 | 2011-03-23 | ユニバーシティー オブ ブリティッシュ コロンビア | 脂質小胞への荷電した治療剤の高率封入 |
US6146659A (en) * | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6461637B1 (en) * | 2000-09-01 | 2002-10-08 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
WO2001056548A2 (en) * | 2000-02-04 | 2001-08-09 | Lipoxen Technologies Limited | Liposomes composition produced by a dehydration-rehydration process |
AU2000239101A1 (en) * | 2000-03-22 | 2001-10-03 | Neopharm, Inc. | A method of administering liposomal encapsulated taxane |
BR0114713A (pt) * | 2000-10-16 | 2004-01-13 | Neopharm Inc | Formulação lipossÈmica de mitoxantrona |
NZ525552A (en) * | 2000-11-09 | 2005-04-29 | Neopharm Inc | SN-38 lipid complexes with cardiolipin and methods of use for the treatment of cancers and multiple sclerosis |
WO2002059337A1 (en) * | 2001-01-26 | 2002-08-01 | Georgetown University School Of Medicine | Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof |
WO2002081639A2 (en) * | 2001-04-06 | 2002-10-17 | Georgetown University | Gene brcc2 and diagnostic and therapeutic uses thereof |
AU2002305151A1 (en) * | 2001-04-06 | 2002-10-21 | Georgetown University | Gene scc-112 and diagnostic and therapeutic uses thereof |
AU2002258728A1 (en) * | 2001-04-06 | 2002-10-21 | Georgetown University | Gene brcc-3 and diagnostic and therapeutic uses thereof |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
WO2003039600A1 (en) * | 2001-11-09 | 2003-05-15 | Neopharm, Inc. | Selective treatment of il-13 expressing tumors |
US7138512B2 (en) * | 2002-04-10 | 2006-11-21 | Georgetown University | Gene SHINC-2 and diagnostic and therapeutic uses thereof |
US7244565B2 (en) * | 2002-04-10 | 2007-07-17 | Georgetown University | Gene shinc-3 and diagnostic and therapeutic uses thereof |
US20050148528A1 (en) * | 2002-05-20 | 2005-07-07 | Neopharm, Inc | Method for reducing platelet count |
US20030228317A1 (en) * | 2002-05-22 | 2003-12-11 | Prafulla Gokhale | Gene BRCC-1 and diagnostic and therapeutic uses thereof |
WO2003099830A2 (en) * | 2002-05-24 | 2003-12-04 | Neopharm, Inc. | Cardiolipin compositions, methods of preparation and use |
EA200401565A1 (ru) * | 2002-05-24 | 2005-04-28 | Неофарм, Инк. | Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты) |
AU2003240934A1 (en) * | 2002-05-29 | 2003-12-19 | Neopharm, Inc. | Method for determining oligonucleotide concentration |
WO2004035032A2 (en) * | 2002-08-20 | 2004-04-29 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
WO2004017944A1 (en) * | 2002-08-23 | 2004-03-04 | Neopharm, Inc. | Liposomal gemcitabine compositions for better drug delivery |
US20050277611A1 (en) * | 2002-10-16 | 2005-12-15 | Neopharm, Inc. | Cationic cardiolipin analoges and its use thereof |
-
2004
- 2004-02-11 WO PCT/US2004/004555 patent/WO2004071466A2/en active Application Filing
- 2004-02-11 JP JP2006503621A patent/JP2006517594A/ja active Pending
- 2004-02-11 BR BR0407415-7A patent/BRPI0407415A/pt not_active Application Discontinuation
- 2004-02-11 CN CNA2004800011941A patent/CN1753657A/zh active Pending
- 2004-02-11 MX MXPA05008489A patent/MXPA05008489A/es not_active Application Discontinuation
- 2004-02-11 EA EA200501285A patent/EA200501285A1/ru unknown
- 2004-02-11 KR KR1020057014387A patent/KR20050105455A/ko not_active Application Discontinuation
- 2004-02-11 EP EP04710304A patent/EP1613284A2/en not_active Withdrawn
-
2005
- 2005-08-11 US US11/201,810 patent/US20060034908A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA05008489A (es) | 2005-10-18 |
BRPI0407415A (pt) | 2006-01-10 |
WO2004071466A2 (en) | 2004-08-26 |
CN1753657A (zh) | 2006-03-29 |
EP1613284A2 (en) | 2006-01-11 |
WO2004071466A3 (en) | 2004-12-02 |
KR20050105455A (ko) | 2005-11-04 |
JP2006517594A (ja) | 2006-07-27 |
US20060034908A1 (en) | 2006-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200501285A1 (ru) | Способ получения липосомальных препаратов | |
HUP0200114A2 (hu) | Bioaktív komplexek kapszulázása liposzómákba | |
WO2002096457A3 (en) | Stable liquid formulations of antibodies | |
Suzuki et al. | Identification of pectenotoxin-11 as 34 S-hydroxypectenotoxin-2, a new pectenotoxin analogue in the toxic dinoflagellate Dinophysis acuta from New Zealand | |
EA200400878A1 (ru) | Новые эфиры флуоренкарбоновых кислот, способ их получения, а также их применение в качестве лекарственных средств | |
WO2004001007A3 (en) | Buffered formulations for concentrating antibodies and methods of use thereof | |
EA200001224A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
NO972608L (no) | Opplösningshjelpemidler for hydrofile makromolekyler | |
KR960700690A (ko) | 리포좀 조성물의 제조방법(Process for producing liposome composition) | |
DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
CA2369070A1 (en) | 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof | |
CR7614A (es) | Preparaciones de insulina acida con estabilidad mejorada | |
EA200200698A1 (ru) | Способ выделения рнк из фиксированных формалином и залитых в парафин образцов ткани | |
WO2001089571A3 (en) | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | |
KR20110128348A (ko) | 염증 및 통증 치료용 화합물 | |
EA200000154A1 (ru) | Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях | |
DE69026820D1 (de) | Zubereitung von liposomen- und lipid-komplexzusammensetzungen | |
PE20011223A1 (es) | Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico | |
DE60222580D1 (de) | Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung | |
ATE289801T1 (de) | Verabreichungssystem für wasserunlösliche arzneistoffe | |
BRPI0414786A (pt) | extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo | |
BG100765A (en) | Process for the preparation of salt of clavulanic acid | |
DE60118742D1 (de) | Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel | |
TW200507867A (en) | Extract of plant dendrobii caulis and preparing process thereof | |
BR0312179A (pt) | Processo para preparação de derivado de epik5-n-o-supersulfato, composição farmacêutica e composição cosmética contendo o mesmo e seu uso |